Artiva Biotherapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | — | $102.8M |
| Jun 2023 | — | — | $53.7M |
| Sep 2023 | — | — | $65.9M |
| Dec 2023 | $50.7M | $105.1M | $53.5M |
| Mar 2024 | — | — | $48.2M |
| Jun 2024 | $50.6M | $75.9M | $34.2M |
| Sep 2024 | $24.6M | $225.6M | $55.9M |
| Dec 2024 | $22.9M | $209.6M | $40.2M |
| Mar 2025 | $22.5M | $191.3M | $30.4M |
| Jun 2025 | $20.4M | $169.4M | $28.5M |
| Sep 2025 | $19.6M | $148.9M | $25.5M |
| Dec 2025 | $21.0M | $130.9M | $26.7M |
| Mar 2026 | $18.1M | $106.0M | $21.0M |
| Jun 2026 | $21.1M | $368.6M | $301.5M |